Navigation Links
New drug to multiple sclerosis symptoms

A new drug AVP-923 is all set to provide relief to people suffering from the dreaded disease of multiple// sclerosis, said the researchers from University of Vermont College of Medicine, US.

Multiple sclerosis is a chronic neurological disease of the central nervous system. The disease affects the brain and spinal cord and medication till date had only been able to treat the problem symptomatically. One of the symptoms of this disease is called pseudobulbar affect is often characterized by episodes of laughter and crying in inappropriate situations. The outbursts are often spontaneous and the patients may have very little control over the expressions.

The new drug will be helping the patients to control much of their inappropriate emotional outbursts. The patients who were given the drug in the clinical trial had also reported of improvement in their quality of life, interpersonal relationships and physical comfort and pain. One of the side effects of the drug was reported to be spells of dizziness.

This is the first drug designed to specifically treat the condition of pseudobulbar affect in patients with multiple sclerosis. The results of the study was presented at the American Academy of Neurology 57th Annual Meeting, held on April 9-16.

Reference: American Academy of Neurology 57th Annual Meeting, Press Release
'"/>




Page: 1

Related medicine news :

1. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
2. Associated therapy for multiple myeloma
3. Latest drug shows promise in multiple myeloma
4. Vitamin D to reduce multiple sclerosis
5. Smoking may affect multiple sclerosis
6. Low immunity in people with multiple sclerosis may be genetical
7. Thalidomide is the new approved drug for treating multiple cancers
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Calcium-blocker delays atherosclerosis than beta-blockers
10. Adult stem cells in treatment for Multiple sclerosis (MS)
11. Vitamin D to reduce multiple sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between Goodwill® and Roadie, ... use or need, from clothes to couches to dressers and bicycles. Roadie — the ... to the nearest Goodwill donation center through February 28th. , “January is an ...
(Date:1/20/2017)... ... 2017 , ... Bionic Sports Nutrition LLC, an American company devoted to developing ... successful January ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition ... provide its products to all clients at reasonable prices. At the ECRM trade show, ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated ... Institute. For Betsy, the clinical trial has been life-saving as she has been ... , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and ... out for each of his children. “The Angel” is the creation of published author, ... New York City, and impassioned writer. , When asked of her new book, Marjorie ...
(Date:1/20/2017)... ... ... “Christmas in Suffolk”: a story of love, secrets, and mystery. “Christmas in ... where she works in a daycare and looks for inspiration in the local coffee ... Publishing, Sara Seymour’s new book is an adventure of love and secrets. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017 The global immunomodulators market is ... according to a new study by Grand View ... predominantly driven by high R&D investments employed by ... of new and therapeutically advanced drugs. This is ... an unprecedented rate into the immunomodulators market hence ...
(Date:1/19/2017)... 2017 Conference Call and Webcast to Follow ... it will release results for the fourth quarter of 2016 on ... ... call at 4:30 PM ET on Wednesday, February 15, 2017, during ... financial results and other corporate activities. To participate in the conference ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
Breaking Medicine Technology: